AINCP’s Post

Our speech pathology team met this week to share some recent professional development completed by team members. We have had speechies recently complete additional training in the Lidcombe Program for children who stutter, Liberator Alternative and Augmentative Communication (AAC) assessment and implementation, and Story Champs for developing narrative and language skills in children. Sharing these resources with the broader team is a great way to share knowledge, ignite insightful discussions about evidence based practice and build connections with each other. #speechpathology #evidencebasedpractice #stuttering #AAC #narrative

#ARVO2024 Update 17: A Randomized Controlled Trial for Myopia Progression Control Using Catenary Power Profile Contact Lenses: 12-month Effectiveness and Safety. Kuang-mon (Ashley) Tuan and co-authors from Visioneering Technologies, Inc., USA. The authors assessed catenary power profile contact lenses that delivers up to +8D add for myopia in children. Children aged 7 to less than 13 years with myopia -0.75D to -5.00D were enrolled from 8 clinical sites and were randomly assigned to SV or caternary curve multifocal contact lenses. Children wearing multifocal lenses experienced a 0.40D (69%) average reduction in myopia progression and 0.17mm (59%) reduction in axial elongation over 12 months, compared to those wearing SV lenses. While 42% of the mutifocal CL wearers showed refractive stability over the year, only 8% of the SVCL group showed the same. These results indicate the lens design’s efficacy in significantly slowing myopia progression and axial elongation in a diverse clinical setting. Abstract link: https://lnkd.in/gPGYiUfE

#ARVO2024 Update 21: Three-year myopia management efficacy of extended depth of focus soft contact lenses (MYLO) in Caucasian children. Sergio Díaz Gómez from Ophtalmology, Miranza COI Bilbao, Spain, and co-authors. This is the first data on the MYLO lens in Caucasian children, following on from Sankaridurg et al 2019's two year RCT in Chinese children. This was a non-randomized study where 98 children wore either the MYLO lens with extended depth of focus optics, or single vision spectacles. After three years, there was 0.74D less myopia progression and 0.42mm less axial elongation in the children wearing MYLO. Questionnaire data on vision and comfort yielded high results and best corrected acuity was reduced by less than one line. Sergio is pictured above with Elena Prieto from mark'ennovy, manufacturer of the MYLO contact lens. Elena presented data on a small study of children wearing the MYLO lens with astigmatism correction compared to those wearing single vision spectacles. The toric myopia control results appeared to be at least as good as the spherical; although the study was smaller (n=21) and the groups weren't quite matched for age. Over one year, 89% of the CL group progressed <0.20mm compared to 10% in the spectacles group. Abstract link spherical data: https://lnkd.in/g7p-2EvX Abstract link toric data: https://lnkd.in/gCbUmuYF #myopia #myopiacontrol #myopiamanagement #professionallearning #research

🎉 Exciting news from NeuroTechR3, Inc.! They have been awarded $287,500 by the U.S. Department of Health and Human Services (HHS)  , Administration for Community Living. This grant will support their innovative project aimed at improving hand and arm function in children with cerebral palsy through affordable and user-friendly exergaming technologies. 🧠 NeurotechR3, in collaboration with the New Jersey Institute of Technology and key stakeholders, will conduct research and development to transform neuroscience principles into an evidence-based medical device. The goal is to create a minimum viable product that can be used by children with mild to moderate cerebral palsy at home and with their therapists, enhancing upper extremity function and independence. 🔬 This project, categorized under research and development, will span 1 year and 11 months, starting from September 1, 2024, to August 31, 2026. #SBIR #STTR #Innovation #Neurotech #Healthcare #PediatricRehabilitation

#ARVO2024 Update 8: Incidence and progression of myopia in young adults. Michael Moore from Technological University Dublin, Ireland, and co-authors. This large-scale study aimed to describe the natural history of myopia progression in myopic patients aged 18-39 years (n=13,185) using anonymised electronic medical records across Irish optometric practices. While the majority of patients had stable myopia, non-stable myopia was highest in younger patients eg. 18-24 yrs (23.4%) and high myopes over 6D (19.9%). Around 8% of adult high myopes showed fast progression of at least 0.50D/year. Younger age and more myopic SER at baseline were predictive of faster myopic progression, and may benefit from myopia management. Abstract link: https://lnkd.in/ge4GK765 #myopia #myopiacontrol #myopiamanagement #professionallearning #research

🛑 Circumcision: It’s Time to Talk About the Harms 🛑 Many men live with the consequences of childhood circumcision without ever knowing the full impact. At 15square, we offer support, education, and resources to help you understand the lifelong effects. 👉 Join us today and learn more: https://lnkd.in/eKD8cEy2 #ForeskinHealth #MensHealth #CircumcisionAwareness

Progressive brain diseases like #ataxia significantly impact speech and communication, necessitating adaptive clinical care strategies. With the deterioration of speech, Alternative and Augmentative Communication (#AAC) can play a big role in daily life. Our review "Optimizing Communication in Ataxia: A Multifaceted Approach to Alternative and Augmentative Communication (AAC)" was published yesterday in Cerebellum. https://lnkd.in/gVSuqFUV The paper provides a wide reaching overview of current AAC technologies, including speech-to-text algorithms and eye gaze technology, brain-computer interfaces and voice banking. Suitable for clinicians, educators and researchers alike. Importantly, the manuscript was co-written with people with lived experience, including case studies describing how they use AAC to communicate. Thanks to co-authors, Thayabaran Kathiresan Jenny Vojtech Peter Gibilisco Scott Blackman Caroline Spencer Katie Burke University of Melbourne UoM Speech Pathology Cara Stepp Boston University Delsys, Inc Indiana University Bloomington Tallaght University Hospital Redenlab Springer Nature Group Springer Healthcare #braincomputerinterface #bci #speech #speechtherapy #speechpathology #rehabilitation #voicebanking #eyegaze #consumer #patients #aac #language #livedexperience #communication

Minute in Medtech: A perspective from an aspiring biomedical engineer, competitive cyclist, CHD Warrior, and typical(?) Teen… In my 17 years of living, I have undergone 10 cardiac interventions: 7 cardiac catheterizations and 3 open-heart surgeries. I had my first open heart surgery at just 2 weeks old, during which Medtronic's Contegra Pulmonary Valved Conduit was installed. By the time I was 2 months old, I needed my second open-heart surgery because my quick-growing heart had outgrown the initial conduit. Essentially, my heart outgrew the device, as it did not grow with me, stretching and limiting blood flow. At 11 years old, I underwent another open-heart surgery to replace the conduit once again. Throughout my journey, various catheterization procedures, such as balloons and stents, have extended the life of each conduit. These interventions have helped maintain effective blood flow, allowing me to lead an active lifestyle. One percent of all babies are born with a congenital heart defect, and 25% of them require cardiac intervention within their first year of life. This staggering statistic makes congenital heart defects one of the most common birth defects worldwide. Renata Medical aims to reduce the need for multiple cardiac interventions with their innovative stent, called "Minima," which grows with the child. Many patients born with congenital heart defects suffer from vascular stenosis, a narrowing of an artery's lumen that reduces necessary blood flow. The Minima stent can be implanted at one day old and expanded through balloon procedures as the patient grows into adolescence and adulthood. It can expand a total of 19mm throughout a patient's life, potentially sparing children like me from future open-heart surgeries. Thank you, Jon Miller, for discussing this innovation with me. I anticipate seeing this device on the market, as it has the potential to save many patients like me from unnecessary hospital stays. Thanks for reading! If you are interested in more of what Renata Medical is doing, check them out using this link: https://lnkd.in/exmUiB2u Follow me at #MinuteInMedtech for more innovative and interesting medical devices. This is my opinion, and I am not being compensated for this post. #healthcare #medicine #medicaldevices #digitalhealth #medtech #medicaldevice #medtechinnovation #medtechinnovator #healthcareinnovation #biomedical #Cardiac #Heart #Stent #Stenosis #Vascular

See you there tomorrow at the first such Telesurgery Consensus Congress #Democratisingsurgery You will learn the latest about new robotic platforms, telecommunications, ethical, legal and social issues about #Telesurgery

TURN BACK TIME 🔙 During the XXIII SIRN National Congress, held in Florence from 15 to 17 February, we introduced the U.Connect platform. This simple, intuitive and functional communication interface allows you to consult and manage data relating to the use of our UAN.GO exoskeleton. The theme of #SIRN24 was "Neuroscience, artificial intelligence and personalized rehabilitation", with the aim of exploring the intersection between advanced research, clinical practice and technological developments that promise to revolutionize this sector. Our U.Connect software moves in this direction, enabling tracking and monitoring of patient progress. #uando #uango #sirn #exoskeleton #rehabilitation #monitoring #uconnect